People Taking Orforglipron Saw Substantial Reductions in Weight and A1C Levels In a 40-week placebo-controlled trial, people with type 2 diabetes taking the highest dose of orforglipron lost 16 pounds on average, or about 7.9 percent of their body weight, and were still losing weight when the study ended
Years of dieting, stress, processed foods or just not knowing what our bodies truly needed can all play a part
Supplementing conventional treatment with pycnogenol(R) may improve hepatitis C virus-associated type 2 diabetes: a mini review
Patients often report renewed energy, better sleep, and clothes fitting differentlypsychological wins that reinforce commitment to the program
Red flags to watch for Any provider who prescribes without a medical evaluation, doesnt require follow-up appointments, or only offers compounded medications without discussing FDA-approved alternatives
Catalfamo et al., 2025)